Latest stories on OGEN
Oragenics gets until February 2028 to regain NYSE listing compliance
Seeking Alpha38 · neutralgeneral
Oragenics Receives NYSE American Approval of Compliance Plan and Extension Through February 2028
GlobeNewswire58 · neutralgeneral
Oragenics Receives NYSE American Approval of Compliance Plan and Extension Through February 2028
Business Insider58 · neutralgeneral
ORAGENICS INC (OGEN) files 8-K
SEC 8-K50 · neutralgeneral
Oragenics Chief Medical Officer to Present at IPAC-RS 2026 Nasal Innovation Forum
Business Insider56 · neutralproduct/pr
Oragenics Chief Medical Officer to Present at IPAC-RS 2026 Nasal Innovation Forum
GlobeNewswire56 · neutralproduct/pr
Oragenics Faces NYSE Compliance Challenges Amid Trial Progress
TipRanks38 · neutralgeneral
ORAGENICS INC (OGEN) files 8-K
SEC 8-K34 · bearishgeneral
Oragenics Reports Continued Clinical Progress, Provides Regulatory and NYSE American Listing Update
Business Insider63 · neutralproduct/pr
Oragenics Reports Continued Clinical Progress, Provides Regulatory and NYSE American Listing Update
GlobeNewswire63 · neutralgeneral
Oragenics Reports Continued Clinical Progress, Provides Regulatory and NYSE American Listing Update
StockTitan63 · neutralproduct/pr
Oragenics Achieves Full Activation of Australian Phase IIa Trial Network — All Three Sites Now Enrolling | OGEN Stock News
StockTitan67 · bullishproduct/pr
Oragenics Appoints New Chief Financial Officer and Leader
TipRanks55 · neutralgeneral
ORAGENICS INC (OGEN) files 8-K
SEC 8-K50 · neutralgeneral
OGEN: [DEF 14A] ORAGENICS INC Definitive Proxy Statement
StockTitan SEC50 · neutralgeneral
Oragenics Highlights Investor Outreach at Micro-Cap Conference
TipRanks55 · neutralgeneral